National Health Investors, Inc. (NHI) Stock Forecast
NHI analyst forecast
as of October 18, 2026- Analyst consensus
- Buy 4.25 / 5 from 8 analysts
- Price target
- $80.88 average of analyst targets
- Upside to target
- +22.0% from the latest close
- Next earnings
- November 9, 2026 EPS estimate $1.16
- 52-week range
- $63.96 – $91.02
NHI analyst ratings
8 analystsNumber of analysts at each rating.
NHI price target
The average of analyst 12-month price targets compared with the latest close and the 52-week range.
NHI earnings per share estimates
| Period | Average | Low | High | Year ago | Growth | Analysts |
|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | $4.56 | $4.56 | $4.56 | $0.69 | +566.1% | 1 |
| Current fiscal year (2026) | $14.55 | $14.55 | $14.55 | $2.93 | +396.6% | 1 |
| Next fiscal year (2027) | $3.35 | $3.26 | $3.45 | $14.55 | −76.9% | 2 |
Consensus EPS estimates; growth compares the average estimate with the year-ago EPS.
NHI revenue estimates
| Period | Average | Low | High | Growth | Analysts |
|---|---|---|---|---|---|
| Current quarter (Sep '26) | $111.4M | $108.0M | $116.5M | +23.9% | 5 |
| Current fiscal year (2026) | $459.7M | $447.6M | $473.3M | +22.4% | 4 |
| Next fiscal year (2027) | $485.9M | $458.7M | $514.5M | +5.7% | 5 |
NHI EPS: reported and forecast
Fiscal years; "E" marks estimates, the line shows the range from the lowest to the highest estimate.
NHI revenue: reported and forecast
NHI EPS estimate revisions
| Period | 90 days ago | 60 days ago | 30 days ago | 7 days ago | Now | Change (90 d) | Revisions (30 d) |
|---|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | $0.86 | $0.93 | $0.93 | $0.00 | $4.56 | +430.7% | 1 up · 0 down |
| Current fiscal year (2026) | $3.61 | $3.67 | $3.67 | $0.00 | $14.55 | +303.1% | 1 up · 0 down |
| Next fiscal year (2027) | $3.45 | $3.31 | $3.25 | $3.25 | $3.35 | −2.8% | 0 up · 1 down |
How the consensus EPS estimate changed over the last 90 days, and how many analysts raised or lowered it in the last 30 days.
NHI earnings surprises
Reported EPS vs the consensus estimate for the last 12 quarters; NHI beat in 7 of 12.
What analysts expect from NHI
8 analysts cover National Health Investors; their consensus rating is buy (4.25 on a 1–5 scale, where 5 is a strong buy). The average price target is $80.88, 22.0% above the latest close of $66.28. Analysts expect earnings of $14.55 per share for 2026, +396.6% from a year earlier. For 2027 the average estimate is $3.35 per share on revenue of $485.9 million. National Health Investors beat the EPS estimate in 7 of the last 12 quarters.
Related: NHI income statement, NHI key metrics, NHI chart. See the NHI stock overview for the latest quote and news.
NHI forecast FAQ
What is National Health Investors's price target?
The average analyst price target for National Health Investors is $80.88, 22.0% above the latest close of $66.28.
Is National Health Investors a buy, hold or sell?
Of 8 analysts covering National Health Investors, 5 rate it a strong buy, 0 a buy, 3 a hold, 0 a sell and 0 a strong sell, a consensus of buy. Ratings are opinions, not a recommendation from Quotelinks.
What is National Health Investors's EPS forecast?
Analysts forecast $14.55 per share for 2026 (range $14.55 to $14.55); for 2027 the estimate is $3.35.
What is National Health Investors's revenue forecast?
The average revenue estimate for 2026 is $459.7 million, growth of 22.4%; for 2027 it is $485.9 million.
When does National Health Investors report earnings?
National Health Investors is expected to report results for the quarter ending September 30, 2026 on November 9, 2026 after the market closes; the EPS estimate is $1.16.
Does National Health Investors usually beat earnings estimates?
National Health Investors reported EPS at or above the analyst estimate in 7 of the last 12 quarters.